June 29, 2012

The upholding of the individual mandate within the Patient Protection and Affordable Care Act by the Supreme Court drew a response from several industry groups, including the Retail Industry Leaders Association.

June 28, 2012

The Supreme Court on Thursday identified the Patient Protection and Affordable Care Act as a tax, which means the constitutionality of the healthcare-reform package cannot be addressed until after that tax is assessed.

June 28, 2012

A new continuing-education program offered by a national pharmacist professional organization aims to prepare pharmacists to communicate with patients about the safe and effective use of the painkiller acetaminophen.

June 28, 2012

The Food and Drug Administration has approved a new drug for treating overactive bladder made by Astellas Pharma, the agency said Thursday.

June 28, 2012

Mylan is challenging the patent protection on a Pfizer drug for treating depression, following an announcement of a similar challenge by Watson made earlier this week.

June 28, 2012

A drug maker and a branch of the National Education Association have released a set of education resources designed to curb prescription drug abuse and misuse.

June 28, 2012

While the Supreme Court on Thursday morning left the Patient Protection and Affordable Care Act mostly intact, the court did rule that Congress cannot withhold federal Medicaid spending from a state that does not expand its eligibility requirements under the act.

June 27, 2012

A bill passed in the Senate will provide measures to speed up the development of treatments for people who desperately need them.

June 27, 2012

The Food and Drug Administration has approved a new treatment for obesity in adults, the agency said Wednesday.

June 27, 2012

The Food and Drug Administration has approved an acne treatment made by Perrigo, the drug maker said Wednesday.

June 26, 2012

The Food and Drug Administration has approved a new Daiichi Sankyo manufacturing center that the company said would strengthen its domestic and global supply chain.

June 26, 2012

The Food and Drug Administration has given tentative approval to Supernus Pharmaceuticals for a drug to treat epilepsy, the company said Tuesday.

June 26, 2012

Generic drug maker Watson Pharmaceuticals is challenging the patent protection on an antidepressant made by Pfizer, the company said.

June 25, 2012

The Food and Drug Administration has approved a generic drug for attention deficit hyperactivity disorder made by Actavis, the drug maker said Monday.

June 25, 2012

A federal court has ruled against Mylan in a case filed by Teva Pharmaceutical Industries over a drug to treat multiple sclerosis.

June 22, 2012

A drug maker has resubmitted its new drug application to the Food and Drug Administration for an acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.

June 22, 2012

The Food and Drug Administration has issued a complete response letter regarding a supplemental new drug application for a medication developed by Janssen Research and Development.

June 22, 2012

A new pilot program that aims to curb prescription drug abuse among patients will be tested in Indiana and Ohio.

June 22, 2012

The National Retail Federation has appointed a retail technology veteran to serve as its VP retail technologies.

June 22, 2012

During its annual Loss Prevention Conference and Expo, the National Retail Federation honored six individuals that exhibited exemplary dedication and investigative skills in solving retail crimes.

June 21, 2012

While the picture of a new Rx-to-OTC switch paradigm is being painted with a broad stroke brush, already there are two divergent pathways emerging around what that new paradigm landscape might look like. 


June 21, 2012

The Food and Drug Administration has approved a new indication for a Pfizer drug.

June 21, 2012

Legislation proposed in the House of Representatives would speed up Food and Drug Administration approval of knock-off versions of vaccines and other biologics while requiring the agency to conduct more inspections of drug factories overseas, according to published reports.

June 21, 2012

A diagnostic test designed to detect the presence of dengue virus in people with symptoms of dengue fever or dengue hemorrhagic fever has been approved by the Food and Drug Administration, the Centers for Disease Control and Prevention announced Thursday.